
Materialise added PEEK implants to its craniomaxillofacial portfolio. The expansion provides surgeons with the flexibility to choose between titanium and PEEK for patient-specific reconstructions, while maintaining the continuity of Materialise’s integrated digital ecosystem — one planning session, one workflow, one partner.
The custom-made implants are now available to surgeons across Europe (excluding Switzerland).
The custom-made PEEK implants are fully integrated into the company’s established CMF portfolio, which includes collaborative 3D planning with dedicated clinical engineers in Mimics Enlight CMF software, seamless case management through Mimics Flow, and fixation with Materialise Standard+ Solutions. This continuity ensures surgeons can select the appropriate material for each clinical indication while maintaining the same validated, traceable process they rely on.
“Personalization isn’t just about material choices but about the precision of the planning process and the reliability of execution,” said Maarten Zandbergen, Market Manager at Materialise. “Our clinical engineers work hand in hand with surgeons to design each implant, and that collaborative approach remains constant whether the case calls for titanium or PEEK. What changes is the surgeon’s freedom to choose; what stays the same is the peace of mind that comes from a proven, end-to-end process.”
Each PEEK implant is manufactured in Europe by Ad Mirabiles, Materialise’s experienced manufacturing partner. Ad Mirabiles operates under an EN ISO 13485 certified quality management system and ensures consistent accuracy across every case. Materialise commits to a 72-hour turnaround time for PEEK implants following surgical plan approval, providing the same reliability the company has established with its titanium portfolio.
Source: Materialise
JAV
Julie A. Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.



